AlphaCentric Advisors’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$120K Sell
1,423
-1,041
-42% -$84K 0.1% 225
2026
Q1
$174K Sell
2,464
-1,192
-33% -$89.2K 0.17% 157
2025
Q4
$289K Buy
+3,656
New +$289K 0.29% 107
2024
Q4
$101K Sell
1,237
-60
-5% -$4.99K 0.1% 161
2024
Q3
$107K Sell
1,297
-41
-3% -$3.06K 0.08% 182
2024
Q2
$93.9K Buy
+1,338
New +$95.5K 0.07% 175
2023
Q2
Sell
-1,977
Closed -$115K 254
2023
Q1
$115K Sell
1,977
-85
-4% -$5.74K 0.08% 175
2022
Q4
$149K Sell
2,062
-2,097
-50% -$150K 0.15% 135
2022
Q3
$253K Buy
+4,159
New +$266K 0.26% 85
2021
Q4
$85K Buy
+1,366
New +$85.7K 0.02% 170
2020
Q4
Sell
-6,786
Closed -$252K 225
2020
Q3
$252K Sell
6,786
-442
-6% -$16.8K 0.12% 33
2020
Q2
$264K Buy
+7,228
New +$252K 0.15% 33

Other funds holding MET

AlphaCentric Advisors's MET Position: Q2 2026 in Review

AlphaCentric Advisors reduced its MetLife (MET) stake by 42% in Q2 2026, selling an estimated $84K and leaving 1,423 shares worth $120K. The position accounts for 0.1% of the portfolio, ranked #225.

AlphaCentric Advisors first reported a position in MET in Q2 2020 and has held it in 12 quarters since. The position peaked at $289K in Q4 2025. 423 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • AlphaCentric Advisors held 1,423 shares of MetLife worth $120K as of Q2 2026.
  • AlphaCentric Advisors sold 1,041 MetLife shares in Q2 2026, an estimated $84K.
  • MetLife made up 0.1% of AlphaCentric Advisors's portfolio in Q2 2026, its #225 holding.
  • AlphaCentric Advisors first reported a position in MetLife in Q2 2020 and has held it in 12 quarters since.
  • AlphaCentric Advisors's MetLife position peaked at $289K in Q4 2025.
  • 423 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.